These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 22745659)
1. Development of a multi-step leukemogenesis model of MLL-rearranged leukemia using humanized mice. Moriya K; Suzuki M; Watanabe Y; Takahashi T; Aoki Y; Uchiyama T; Kumaki S; Sasahara Y; Minegishi M; Kure S; Tsuchiya S; Sugamura K; Ishii N PLoS One; 2012; 7(6):e37892. PubMed ID: 22745659 [TBL] [Abstract][Full Text] [Related]
2. Plzf drives MLL-fusion-mediated leukemogenesis specifically in long-term hematopoietic stem cells. Ono R; Masuya M; Nakajima H; Enomoto Y; Miyata E; Nakamura A; Ishii S; Suzuki K; Shibata-Minoshima F; Katayama N; Kitamura T; Nosaka T Blood; 2013 Aug; 122(7):1271-83. PubMed ID: 23838347 [TBL] [Abstract][Full Text] [Related]
3. MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment. Stubbs MC; Kim YM; Krivtsov AV; Wright RD; Feng Z; Agarwal J; Kung AL; Armstrong SA Leukemia; 2008 Jan; 22(1):66-77. PubMed ID: 17851551 [TBL] [Abstract][Full Text] [Related]
4. Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models. Ono R; Masuya M; Inoue N; Shinmei M; Ishii S; Maegawa Y; Maharjan BD; Katayama N; Nosaka T PLoS One; 2021; 16(3):e0248425. PubMed ID: 33705482 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of RUNX1/CBFβ by MLL fusion proteins enhances hematopoietic stem cell self-renewal. Zhao X; Chen A; Yan X; Zhang Y; He F; Hayashi Y; Dong Y; Rao Y; Li B; Conway RM; Maiques-Diaz A; Elf SE; Huang N; Zuber J; Xiao Z; Tse W; Tenen DG; Wang Q; Chen W; Mulloy JC; Nimer SD; Huang G Blood; 2014 Mar; 123(11):1729-38. PubMed ID: 24449215 [TBL] [Abstract][Full Text] [Related]
7. Enforced expression of MLL-AF4 fusion in cord blood CD34+ cells enhances the hematopoietic repopulating cell function and clonogenic potential but is not sufficient to initiate leukemia. Montes R; Ayllón V; Gutierrez-Aranda I; Prat I; Hernández-Lamas MC; Ponce L; Bresolin S; Te Kronnie G; Greaves M; Bueno C; Menendez P Blood; 2011 May; 117(18):4746-58. PubMed ID: 21389315 [TBL] [Abstract][Full Text] [Related]
8. EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs. Bindels EM; Havermans M; Lugthart S; Erpelinck C; Wocjtowicz E; Krivtsov AV; Rombouts E; Armstrong SA; Taskesen E; Haanstra JR; Beverloo HB; Döhner H; Hudson WA; Kersey JH; Delwel R; Kumar AR Blood; 2012 Jun; 119(24):5838-49. PubMed ID: 22553314 [TBL] [Abstract][Full Text] [Related]
9. Involvement of Gpr125 in the myeloid sarcoma formation induced by cooperating MLL/AF10(OM-LZ) and oncogenic KRAS in a mouse bone marrow transplantation model. Fu JF; Yen TH; Chen Y; Huang YJ; Hsu CL; Liang DC; Shih LY Int J Cancer; 2013 Oct; 133(8):1792-802. PubMed ID: 23564351 [TBL] [Abstract][Full Text] [Related]
10. Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis. Ono R; Nakajima H; Ozaki K; Kumagai H; Kawashima T; Taki T; Kitamura T; Hayashi Y; Nosaka T J Clin Invest; 2005 Apr; 115(4):919-29. PubMed ID: 15761502 [TBL] [Abstract][Full Text] [Related]
11. Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia. Aoki Y; Watanabe T; Saito Y; Kuroki Y; Hijikata A; Takagi M; Tomizawa D; Eguchi M; Eguchi-Ishimae M; Kaneko A; Ono R; Sato K; Suzuki N; Fujiki S; Koh K; Ishii E; Shultz LD; Ohara O; Mizutani S; Ishikawa F Blood; 2015 Feb; 125(6):967-80. PubMed ID: 25538041 [TBL] [Abstract][Full Text] [Related]
12. t(10;11)-acute leukemias with MLL-AF10 and MLL-ABI1 chimeric transcripts: specific expression patterns of ABI1 gene in leukemia and solid tumor cell lines. Shibuya N; Taki T; Mugishima H; Chin M; Tsuchida M; Sako M; Kawa K; Ishii E; Miura I; Yanagisawa M; Hayashi Y Genes Chromosomes Cancer; 2001 Sep; 32(1):1-10. PubMed ID: 11477655 [TBL] [Abstract][Full Text] [Related]
13. Transcriptional activation by MLL fusion proteins in leukemogenesis. Yokoyama A Exp Hematol; 2017 Feb; 46():21-30. PubMed ID: 27865805 [TBL] [Abstract][Full Text] [Related]
14. MLL/AF10(OM-LZ)-immortalized cells expressed cytokines and induced host cell proliferation in a mouse bone marrow transplantation model. Fu JF; Hsu CL; Shih LY Int J Cancer; 2010 Apr; 126(7):1621-9. PubMed ID: 19711340 [TBL] [Abstract][Full Text] [Related]
15. Frat2 mediates the oncogenic activation of Rac by MLL fusions. Walf-Vorderwülbecke V; de Boer J; Horton SJ; van Amerongen R; Proost N; Berns A; Williams O Blood; 2012 Dec; 120(24):4819-28. PubMed ID: 23074275 [TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of MLL-associated leukemia. Yokoyama A Int J Hematol; 2015 Apr; 101(4):352-61. PubMed ID: 25773519 [TBL] [Abstract][Full Text] [Related]
17. Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia. Wei J; Wunderlich M; Fox C; Alvarez S; Cigudosa JC; Wilhelm JS; Zheng Y; Cancelas JA; Gu Y; Jansen M; Dimartino JF; Mulloy JC Cancer Cell; 2008 Jun; 13(6):483-95. PubMed ID: 18538732 [TBL] [Abstract][Full Text] [Related]
18. Cooperation of MLL/AF10(OM-LZ) with PTPN11 activating mutation induced monocytic leukemia with a shorter latency in a mouse bone marrow transplantation model. Fu JF; Liang ST; Huang YJ; Liang KH; Yen TH; Liang DC; Shih LY Int J Cancer; 2017 Mar; 140(5):1159-1172. PubMed ID: 27859216 [TBL] [Abstract][Full Text] [Related]